BlueBox Precision Medicine Fund Class S Fonds
1.131,76
USD
-34,57
USD
-2,96
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 6,30% |
| Lonza Group Ltd | CH0013841017 | 6,16% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,36% |
| Sartorius Stedim Biotech SA | FR0013154002 | 5,29% |
| argenx SE | NL0010832176 | 5,27% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 4,96% |
| Nuvalent Inc Class A | US6707031075 | 4,40% |
| SpringWorks Therapeutics Inc Ordinary Shares | US85205L1070 | 4,29% |
| Natera Inc | US6323071042 | 4,26% |
| Blueprint Medicines Corp | US09627Y1091 | 4,14% |
| Sonstige | 49,58% |